Omeros Management

Management criteria checks 2/4

Omeros' CEO is Greg Demopulos, appointed in Jun 1994, has a tenure of 30.25 years. total yearly compensation is $7.69M, comprised of 11.9% salary and 88.1% bonuses, including company stock and options. directly owns 3.5% of the company’s shares, worth €6.50M. The average tenure of the management team and the board of directors is 4.8 years and 17.8 years respectively.

Key information

Greg Demopulos

Chief executive officer

US$7.7m

Total compensation

CEO salary percentage11.9%
CEO tenure30.3yrs
CEO ownership3.5%
Management average tenure4.8yrs
Board average tenure17.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Greg Demopulos's remuneration changed compared to Omeros's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$200m

Mar 31 2024n/an/a

-US$179m

Dec 31 2023US$8mUS$917k

-US$175m

Sep 30 2023n/an/a

-US$182m

Jun 30 2023n/an/a

-US$185m

Mar 31 2023n/an/a

-US$182m

Dec 31 2022US$4mUS$882k

-US$182m

Sep 30 2022n/an/a

-US$183m

Jun 30 2022n/an/a

-US$173m

Mar 31 2022n/an/a

-US$181m

Dec 31 2021US$7mUS$848k

-US$192m

Sep 30 2021n/an/a

-US$217m

Jun 30 2021n/an/a

-US$211m

Mar 31 2021n/an/a

-US$194m

Dec 31 2020US$6mUS$817k

-US$173m

Sep 30 2020n/an/a

-US$130m

Jun 30 2020n/an/a

-US$108m

Mar 31 2020n/an/a

-US$89m

Dec 31 2019US$5mUS$794k

-US$147m

Sep 30 2019n/an/a

-US$79m

Jun 30 2019n/an/a

-US$102m

Mar 31 2019n/an/a

-US$121m

Dec 31 2018US$5mUS$770k

-US$127m

Sep 30 2018n/an/a

-US$120m

Jun 30 2018n/an/a

-US$88m

Mar 31 2018n/an/a

-US$68m

Dec 31 2017US$5mUS$748k

-US$53m

Compensation vs Market: Greg's total compensation ($USD7.69M) is above average for companies of similar size in the German market ($USD780.99K).

Compensation vs Earnings: Greg's compensation has increased whilst the company is unprofitable.


CEO

Greg Demopulos (65 yo)

30.3yrs

Tenure

US$7,689,843

Compensation

Dr. Gregory A. Demopulos, M.D., also known as Greg, founded Omeros Corporation in June 1994 and has been its Chairman of the Board, Chief Executive Officer and President since June 1994. Dr. Demopulos serv...


Leadership Team

NamePositionTenureCompensationOwnership
Gregory Demopulos
Co-Founder30.3yrsUS$7.69m3.5%
$ 6.5m
Peter Cancelmo
VP, General Counsel & Corporate Secretary5.3yrsUS$852.63k0.00035%
$ 650.3
Pamela Palmer
Co-Founderno datano datano data
David Borges
VP of Financeless than a yearno data0.052%
$ 96.2k
George Gaitanaris
Chief Scientific Officer & VP of Science12.7yrsno datano data
Peter Williams
Vice President of Human Resources4.3yrsno datano data
Catherine Melfi
Chief Regulatory Officer & VP of Regulatory Affairs and Quality Systems11.9yrsno datano data
Nadia Dac
VP & Chief Commercial Officer3.7yrsno datano data
Andreas Grauer
VP & Chief Medical Officerless than a yearno datano data

4.8yrs

Average Tenure

61yo

Average Age

Experienced Management: 3O8's management team is considered experienced (4.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Gregory Demopulos
Co-Founder30.3yrsUS$7.69m3.5%
$ 6.5m
Thomas Cable
Lead Independent Director29.7yrsUS$177.60k0.061%
$ 112.5k
Leroy Hood
Independent Director23.5yrsUS$135.10k0.13%
$ 238.5k
Arnold Hanish
Independent Director12yrsUS$137.60k0.021%
$ 39.8k
Peter Demopulos
Director29.7yrsUS$122.60k0.64%
$ 1.2m
Thomas Bumol
Independent Director5.6yrsUS$127.60k0.017%
$ 32.1k
Rajiv Shah
Independent Director9.3yrsUS$140.10k0%
$ 0
Diana Perkinson
Independent Director1.3yrsUS$174.66k0%
$ 0

17.8yrs

Average Tenure

70yo

Average Age

Experienced Board: 3O8's board of directors are seasoned and experienced ( 17.8 years average tenure).